Drug:
Reaction: INJECTION SITE PAIN
20260101 - 20261231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 26940078 |
US |
60 | 2 |
Fatigue, Injection site erythema, Injection site pruritus, Injection site swelling, Injection site pain, |
||||
ETANERCEPT, ETANERCEPT, |
||||
| 2 | 26940329 |
US |
72 | 1 |
Blood pressure fluctuation, Heart rate increased, Injection site erythema, Injection site pain, |
||||
ABALOPARATIDE, ABALOPARATIDE, ERGOCALCIFEROL, MAGNESIUM, MAGNESIUM, TADALAFIL, AMLODIPINE BESYLATE, LOSARTAN POTASSIUM, LOSARTAN, LOSARTAN POTASSIUM, LOSARTAN, |
||||
| 3 | 26940382 |
US |
2 | |
Injection site discomfort, Chest pain, Pain in jaw, Urine odour abnormal, Anxiety, Injection site pain, Injection site reaction, Injection site bruising, Dizziness, Headache, Arthralgia, Bone pain, Product distribution issue, Product dose omission in error, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, TOPIRAMATE, |
||||
| 4 | 26940389 |
US |
1 | |
Catheterisation cardiac, Weight increased, Injection site pain, Injection site haemorrhage, Device defective, Drug dose omission by device, Needle issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, SUVOREXANT, OXYBUTYNIN CHLORIDE, |
||||
| 5 | 26940457 |
US |
59 | 1 |
Injection site pain, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, ALBUTEROL SULFATE, EZETIMIBE, FERROUS SULFATE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, SIMVASTATIN, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, CETIRIZINE HYDROCHLORIDE, |
||||
| 6 | 26940474 |
US |
46 | 1 |
Injection site pain, Product preparation issue, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 7 | 26940483 |
US |
8 | 1 |
Injection site erythema, Injection site pain, Injection site pruritus, |
||||
DUPILUMAB, |
||||
| 8 | 26940493 |
US |
2 | |
Injection site pain, |
||||
DUPILUMAB, |
||||
| 9 | 26940502 |
US |
2 | |
Psoriatic arthropathy, Psoriasis, Oral candidiasis, Injection site pain, |
||||
BIMEKIZUMAB, |
||||
| 10 | 26940555 |
US |
2 | |
Cognitive disorder, Muscular weakness, Feeling abnormal, Injection site pain, Injection site bruising, Nausea, Dizziness, Abdominal distension, Headache, Constipation, Arthralgia, Fatigue, |
||||
ABALOPARATIDE, |
||||
| 11 | 26940589 |
US |
20 | 2 |
Injection site pain, Injection site mass, Injection site pruritus, Injection site erythema, Injection site pain, Injection site haemorrhage, Injection site mass, |
||||
GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, |
||||
| 12 | 26940736 |
US |
66 | 2 |
Forearm fracture, Productive cough, Hypersensitivity, Injection site pain, |
||||
ABALOPARATIDE, |
||||
| 13 | 26940758 |
US |
2 | |
Injection site discomfort, Injection site pain, |
||||
ABALOPARATIDE, |
||||
| 14 | 26940790 |
US |
2 | |
Injection site nodule, Injection site bruising, Injection site pain, |
||||
ABALOPARATIDE, |
||||
| 15 | 26940806 |
US |
2 | |
Vascular injury, Peripheral swelling, Skin discolouration, Fatigue, Heart rate increased, Dizziness, Injection site pain, Pruritus, Rash, Arthralgia, Diarrhoea, Insomnia, |
||||
ABALOPARATIDE, |
||||
| 16 | 26940865 |
US |
2 | |
Palpitations, Injection site pain, Fatigue, Product use in unapproved indication, Dizziness, Sinusitis, Balance disorder, |
||||
ABALOPARATIDE, ABALOPARATIDE, FISH OIL, IRON, PAROXETINE HYDROCHLORIDE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ERGOCALCIFEROL, |
||||
| 17 | 26940871 |
BR |
2 | |
Injection site pain, |
||||
TRIPTORELIN PAMOATE, |
||||
| 18 | 26940876 |
US |
57 | 1 |
Incorrect dose administered, Injection site pain, |
||||
TIRZEPATIDE, |
||||
| 19 | 26940986 |
US |
2 | |
Presyncope, Paraesthesia, Brain fog, Sensory disturbance, Injection site discomfort, Upper-airway cough syndrome, Respiratory tract infection, Nasopharyngitis, Vertigo, Dizziness, Muscle spasms, Nausea, Headache, Fatigue, Injection site pain, Injection site bruising, Constipation, Abdominal pain upper, Abdominal distension, Malaise, Pain in extremity, Diarrhoea, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, ROSUVASTATIN, |
||||
| 20 | 26941042 |
US |
2 | |
Fatigue, Headache, Muscle spasms, Dizziness, Injection site pain, Device defective, |
||||
ABALOPARATIDE, |
||||
| 21 | 26941099 |
US |
2 | |
Vitamin D deficiency, Blood pressure fluctuation, Feeling abnormal, Tachycardia, Blood pressure increased, Heart rate increased, Palpitations, Injection site pain, Injection site bruising, Headache, Accidental overdose, Product dose omission issue, Circumstance or information capable of leading to medication error, |
||||
ABALOPARATIDE, |
||||
| 22 | 26941109 |
US |
2 | |
Anxiety, Heart rate increased, Headache, Bone pain, Injection site bruising, Injection site pain, |
||||
ABALOPARATIDE, |
||||
| 23 | 26941126 |
US |
31 | 2 |
Injection site abscess, Injection site pain, |
||||
CABOTEGRAVIR AND RILPIVIRINE, CABOTEGRAVIR AND RILPIVIRINE, CABOTEGRAVIR AND RILPIVIRINE, |
||||
| 24 | 26941133 |
US |
2 | |
Abdominal hernia, Injection site pain, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, CELECOXIB, |
||||
| 25 | 26941140 |
US |
2 | |
Injection site pain, Injection site bruising, Nausea, Vomiting, Weight decreased, Product dose omission in error, Off label use, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, |
||||
| 26 | 26941184 |
US |
2 | |
Nasal dryness, Cough, Injection site pain, |
||||
ABALOPARATIDE, |
||||
| 27 | 26941192 |
US |
64 | 2 |
Injection site urticaria, Injection site haemorrhage, Injection site pain, |
||||
EVOLOCUMAB, |
||||
| 28 | 26941280 |
US |
65 | 2 |
Injection site pain, |
||||
TIRZEPATIDE, |
||||
| 29 | 26941326 |
US |
36 | 2 |
Weight bearing difficulty, Gait disturbance, Injection site pain, Injection site swelling, Injection site bruising, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 30 | 26941329 |
US |
78 | 2 |
Injection site pain, Injection site discomfort, |
||||
DUPILUMAB, ALBUTEROL SULFATE, ALBUTEROL SULFATE, BACLOFEN, EZETIMIBE, FLECAINIDE ACETATE TABLET, FLECAINIDE ACETATE, HYDROCODONE BITARTRATE AND ACETAMINOPHEN, IBANDRONATE SODIUM, IPRATROPIUM BROMIDE, LETROZOLE, LETROZOLE TABLETS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LIDOCAINE AND PRILOCAINE, LOSARTAN POTASSIUM, LOSARTAN, TIOTROPIUM BROMIDE INHALATION SPRAY, VITAMIN C, TIRZEPATIDE, |
||||
| 31 | 26941380 |
US |
||
Injection site pain, |
||||
BUROSUMAB, |
||||
| 32 | 26941415 |
US |
2 | |
Needle issue, Injection site pain, |
||||
USTEKINUMAB, USTEKINUMAB, |
||||
| 33 | 26941517 |
US |
2 | |
Brain fog, Eye pain, Breast discomfort, Fatigue, Injection site pain, Drug dose omission by device, Device issue, |
||||
ABALOPARATIDE, |
||||
| 34 | 26941546 |
US |
2 | |
Anxiety, Hot flush, Injection site pain, Heart rate increased, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, CELECOXIB, LOSARTAN POTASSIUM, ATORVASTATIN CALCIUM, TIRZEPATIDE, |
||||
| 35 | 26941560 |
US |
62 | 2 |
Gastrooesophageal reflux disease, Condition aggravated, Influenza like illness, Injection site pain, Arthralgia, Headache, Pain, Intentional dose omission, Liquid product physical issue, |
||||
ABALOPARATIDE, FAMOTIDINE, |
||||
| 36 | 26941670 |
US |
67 | 1 |
Injection site inflammation, Injection site pain, |
||||
INSULIN GLARGINE, |
||||
| 37 | 26941679 |
US |
2 | |
Abdominoplasty, Injection site pain, Bacterial vaginosis, |
||||
ABALOPARATIDE, AMLODIPINE BESYLATE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, FLUTICASONE PROPIONATE, HYDROCHLOROTHIAZIDE, MONTELUKAST, PANTOPRAZOLE, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, PREGABALIN, ROSUVASTATIN, RIVAROXABAN, |
||||
| 38 | 26941684 |
US |
13 | 1 |
Musculoskeletal stiffness, Neck pain, Injection site pain, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 39 | 26941687 |
US |
77 | 2 |
Glaucoma, Plantar fasciitis, Injection site pain, |
||||
DUPILUMAB, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROXYZINE, PANTOPRAZOLE, ROSUVASTATIN, ERGOCALCIFEROL, |
||||
| 40 | 26941691 |
US |
66 | 1 |
Injection site pain, Injection site erythema, |
||||
DUPILUMAB, |
||||
| 41 | 26941712 |
US |
||
Injection site pain, |
||||
DUPILUMAB, |
||||
| 42 | 26941715 |
US |
35 | 2 |
Injection site pain, |
||||
DUPILUMAB, |
||||
| 43 | 26941749 |
US |
2 | |
Hospitalisation, Emergency care, Spinal pain, Musculoskeletal pain, Injection site pain, Product dose omission issue, Product use issue, |
||||
ABALOPARATIDE, |
||||
| 44 | 26941787 |
US |
2 | |
Fear of injection, Injection site pain, Intentional dose omission, |
||||
ABALOPARATIDE, |
||||
| 45 | 26941824 |
US |
60 | 2 |
Paraesthesia, Burning sensation, Headache, Heart rate increased, Nausea, Vomiting, Pain, Pain in extremity, Pain in extremity, Pain in extremity, Injection site pain, Myalgia, Hypoaesthesia, |
||||
ABALOPARATIDE, CALCIUM, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, CYCLOBENZAPRINE, FISH OIL, PREGABALIN, OMEPRAZOLE MAGNESIUM, PROCHLORPERAZINE, VITAMIN C, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, |
||||
| 46 | 26941835 |
US |
2 | |
Dyspepsia, Crepitations, Palpitations, Injection site pain, Wrong technique in product usage process, Product dose omission issue, Product communication issue, |
||||
ABALOPARATIDE, SIMVASTATIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 47 | 26941881 |
US |
2 | |
Injection related reaction, Burning sensation, Injection site irritation, Pain, Pruritus, Injection site erythema, Injection site pain, |
||||
ABALOPARATIDE, |
||||
| 48 | 26941894 |
US |
2 | |
Contusion, Injection site pain, Product dose omission issue, Product use issue, |
||||
ABALOPARATIDE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 49 | 26941940 |
US |
24 | 2 |
Injection site induration, Injection site warmth, Cellulitis, Abdominal distension, Joint swelling, Abdominal discomfort, Vomiting, Dehydration, Injection site pain, |
||||
OCRELIZUMAB AND HYALURONIDASE, DROSPIRENONE, |
||||
| 50 | 26942035 |
US |
68 | 2 |
Adjustment disorder with depressed mood, Flatulence, Injection site pain, Injection site haemorrhage, Pain, Nausea, Headache, |
||||
ABALOPARATIDE, PROPAFENONE, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, ROSUVASTATIN, SERTRALINE, |
||||
| 51 | 26942124 |
US |
18 | 2 |
Injection site pain, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 52 | 26942127 |
US |
2 | |
Muscle spasms, Injection site pain, |
||||
DUPILUMAB, |
||||
| 53 | 26942134 |
US |
6 | 1 |
Dry skin, Injection site pain, |
||||
DUPILUMAB, |
||||
| 54 | 26942142 |
US |
45 | 2 |
Injection site pain, |
||||
DUPILUMAB, |
||||
| 55 | 26942158 |
US |
2 | |
Injection site pain, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 56 | 26942166 |
US |
18 | 2 |
Injection site pain, |
||||
DUPILUMAB, |
||||
| 57 | 26942263 |
US |
69 | 2 |
Injection site pain, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 58 | 26942337 |
US |
44 | 1 |
Injection site pain, Wrong technique in product usage process, Incorrect dose administered, Accidental exposure to product, |
||||
FREMANEZUMAB-VFRM, |
||||
| 59 | 26942354 |
US |
70 | 1 |
Tremor, Injection site pain, Injection site bruising, |
||||
ANAKINRA, |
||||
| 60 | 26942427 |
US |
2 | |
Injection site pain, |
||||
DUPILUMAB, |
||||
| 61 | 26942454 |
US |
2 | |
Illness, Upper respiratory tract infection, Injection site pain, |
||||
DUPILUMAB, |
||||
| 62 | 26942455 |
US |
22 | |
Injection site pain, |
||||
DUPILUMAB, |
||||
| 63 | 26942462 |
US |
29 | 1 |
Injection site pain, |
||||
DUPILUMAB, |
||||
| 64 | 26942517 |
US |
70 | 2 |
Injection site pain, Wrong technique in product usage process, |
||||
EVOLOCUMAB, |
||||
| 65 | 26942821 |
US |
34 | 2 |
Injection site pain, |
||||
DUPILUMAB, |
||||
| 66 | 26942822 |
US |
56 | 2 |
Injection site pain, |
||||
DUPILUMAB, |
||||
| 67 | 26942828 |
US |
44 | 2 |
Injection site pain, Injection site swelling, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 68 | 26943013 |
US |
47 | 2 |
Injection site pain, |
||||
TRALOKINUMAB-LDRM, |
||||
| 69 | 26943057 |
CA |
||
Drug ineffective, Pain in extremity, Wound, Injection site irritation, Injection site erythema, Urticaria, Blood immunoglobulin G increased, Injection site pruritus, Peripheral swelling, Gastrointestinal disorder, Impaired healing, Injection site pain, Blood immunoglobulin G decreased, Illness, Discomfort, Rash, Fear of injection, |
||||
PEGINTERFERON BETA-1A, PEGINTERFERON BETA-1A, PEGINTERFERON BETA-1A, PEGINTERFERON BETA-1A, PEGINTERFERON BETA-1A, PEGINTERFERON BETA-1A, HUMAN IMMUNOGLOBULIN G, PRAZOSIN HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, MORPHINE SULFATE, MORPHINE SULFATE, PREGABALIN, DIMENHYDRINATE, SERTRALINE HYDROCHLORIDE, SUMATRIPTAN SUCCINATE, |
||||
| 70 | 26943072 |
US |
55 | 1 |
Injection site pain, |
||||
TIRZEPATIDE, |
||||
| 71 | 26943265 |
US |
47 | 2 |
Injection site swelling, Injection site erythema, Injection site pain, |
||||
DUPILUMAB, |
||||
| 72 | 26943294 |
US |
66 | 2 |
Injection site pain, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 73 | 26943448 |
US |
49 | 2 |
Eye pruritus, Sleep disorder, Injection site pain, Mood disorder due to a general medical condition, |
||||
TRALOKINUMAB-LDRM, TRALOKINUMAB-LDRM, |
||||
| 74 | 26943513 |
US |
1 | |
Injection site reaction, Injection site pain, Headache, |
||||
PEGVALIASE-PQPZ, |
||||
| 75 | 26943540 |
US |
2 | |
Injection site pain, Device difficult to use, Drug dose omission by device, |
||||
EVOLOCUMAB, |
||||
| 76 | 26943567 |
US |
80 | 2 |
Injection site pain, |
||||
DULAGLUTIDE, |
||||
| 77 | 26943597 |
US |
2 | |
Injection site pain, Injection site mass, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 78 | 26944180 |
US |
67 | 2 |
Injection site pain, |
||||
DUPILUMAB, |
||||
| 79 | 26944443 |
CA |
44 | 2 |
Loss of consciousness, Injection site pain, Device difficult to use, |
||||
OFATUMUMAB, |
||||
| 80 | 26944489 |
US |
||
Injection site pain, |
||||
TIRZEPATIDE, |
||||
| 81 | 26944582 |
US |
1 | |
Injection site pain, |
||||
DUPILUMAB, |
||||
| 82 | 26944674 |
US |
58 | 2 |
Injection site pain, |
||||
TIRZEPATIDE, |
||||
| 83 | 26944683 |
US |
2 | |
Illness, Sensitive skin, Injection site pain, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 84 | 26944823 |
US |
2 | |
Sensory disturbance, Injection site pain, Injection site bruising, Dizziness, Product administered at inappropriate site, Incorrect route of product administration, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, |
||||
| 85 | 26944824 |
US |
2 | |
Blood urine present, Gastrooesophageal reflux disease, Balance disorder, Polyuria, Musculoskeletal discomfort, Blood pressure increased, Injection site pain, Injection site erythema, Injection site swelling, Injection site reaction, Nausea, Fatigue, Vertigo, Asthenia, Renal disorder, Blood glucose increased, Product dose omission issue, Liquid product physical issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, AMLODIPINE BESYLATE, VALSARTAN, VALSARTAN ORAL, HYOSCYAMINE SULFATE, MAGNESIUM, FLUTICASONE PROPIONATE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, TAMSULOSIN HYDROCHLORIDE, PEPPERMINT OIL, |
||||
| 86 | 26944956 |
US |
2 | |
Musculoskeletal stiffness, Pain, Headache, Injection site pain, |
||||
ABALOPARATIDE, CARBIDOPA AND LEVODOPA, CEPHALEXIN, GABAPENTIN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, |
||||
| 87 | 26944958 |
US |
2 | |
Pollakiuria, Thirst, Headache, Injection site pain, Pain, Bone pain, Back pain, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ARIPIPRAZOLE, ALBUTEROL SULFATE, AMLODIPINE BESYLATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CALCIUM, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, DULOXETINE HYDROCHLORIDE, DULOXETINE, EZETIMIBE, ISOSORBIDE MONONITRATE, LOSARTAN POTASSIUM, LOSARTAN, MAGNESIUM, METHOCARBAMOL, METHOCARBAMOL TABLETS, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, NITROGLYCERIN, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, ROSUVASTATIN, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, PRASUGREL HYDROCHLORIDE, |
||||
| 88 | 26944969 |
US |
4 | 2 |
Injection site pain, Needle issue, |
||||
DUPILUMAB, |
||||
| 89 | 26945001 |
US |
2 | |
Injection site mass, Injection site pain, Needle issue, |
||||
ABALOPARATIDE, |
||||
| 90 | 26945017 |
US |
2 | |
Weight increased, Injection site pain, |
||||
ABALOPARATIDE, |
||||
| 91 | 26945026 |
US |
2 | |
Somnolence, Illness, Blood pressure decreased, Decreased appetite, Injection site pain, Injection site erythema, Injection site swelling, Back pain, Nausea, Dizziness, Fatigue, |
||||
ABALOPARATIDE, FEXOFENADINE HYDROCHLORIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BIOTIN, DIPHENHYDRAMINE HYDROCHLORIDE, CALCIUM, FISH OIL, FLUTICASONE PROPIONATE, LORAZEPAM, POLYETHYLENE GLYCOL 3350, MONTELUKAST, RIMEGEPANT SULFATE, MAGNESIUM, DOCUSATE SODIUM, SENNOSIDES, DOCUSATE SODIUM AND SENNOSIDES, SENNOSIDES AND DOCUSATE SODIUM, DOCUSATE SODIUM SENNOSIDES, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, CYANOCOBALAMIN, ERGOCALCIFEROL, |
||||
| 92 | 26945027 |
US |
74 | 2 |
Chills, Pyrexia, Eczema, Headache, Injection site pain, Rash, Injection site reaction, |
||||
ABALOPARATIDE, ABALOPARATIDE, CALCIUM, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, POLYETHYLENE GLYCOL 3350, FAMOTIDINE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ERGOCALCIFEROL, |
||||
| 93 | 26945056 |
US |
2 | |
Mood altered, Dyspepsia, Pollakiuria, Injection site mass, Asthenia, Headache, Pain in extremity, Palpitations, Heart rate increased, Injection site haemorrhage, Injection site bruising, Injection site pain, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, |
||||
| 94 | 26945065 |
US |
2 | |
Injection site pain, Blood pressure decreased, Dizziness, Headache, Fatigue, Arthralgia, Bone pain, Pain in jaw, |
||||
ABALOPARATIDE, |
||||
| 95 | 26945072 |
US |
2 | |
Weight decreased, Musculoskeletal stiffness, Cough, Nausea, Headache, Injection site pain, Diarrhoea, Abdominal discomfort, |
||||
ABALOPARATIDE, NINTEDANIB, |
||||
| 96 | 26945147 |
US |
2 | |
Injection site pain, Injection site nodule, |
||||
PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, |
||||
| 97 | 26945254 |
US |
2 | |
Umbilical hernia, Hernia pain, Injection site pain, |
||||
ABALOPARATIDE, |
||||
| 98 | 26945256 |
US |
2 | |
Injection site pain, Wrong technique in product usage process, Drug delivery system malfunction, Product dose omission issue, Liquid product physical issue, Device leakage, |
||||
ABALOPARATIDE, ABALOPARATIDE, ROSUVASTATIN, LISINOPRIL, FAMOTIDINE, |
||||
| 99 | 26945290 |
US |
2 | |
Injection site discolouration, Injection site nodule, Injection site erythema, Injection site pain, Liquid product physical issue, |
||||
ABALOPARATIDE, |
||||
| 100 | 26945394 |
US |
2 | |
Injection site mass, Hyperaesthesia teeth, Injection site erythema, Injection site pain, |
||||
ABALOPARATIDE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30
